WHO Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

WHO recently issued an “Early Release Guideline” on when to start antiretroviral therapy and on pre-exposure prophylaxis (PrEP) for HIV. This document recommends 1) initiation of ART in adults living with HIV, regardless of CD4 cell count, and 2) offer of PrEP as a prevention option to all people at substantial risk of acquiring HIV. (The release is “early” relative to a comprehensive update of its consolidated ARV guidelines, slated to come out at the end of the year.) If implemented, these sweeping recommendations have the potential to change the world by simplifying ART for people living with HIV and revolutionizing prevention for people at risk.

In this webinar, Meg Doherty and Bob Grant from the Department of HIV/AIDS at WHO, spoke about the guideline and took questions. Links to the full presentation, slides and audio are below.

And for more background, Meg Doherty gave a presentation at IAS 2015 in Vancouver. Download the slides or view the presentation.